David Moss | executive |
Raymond Tesi | executive |
Mark Lowdell | executive |
Joel Beatty | analyst |
Daniel Carlson | analyst |
Ladies and gentlemen, greetings, and welcome to the INmune Bio Fourth Quarter 2023 Earnings Call. [Operator Instructions].
As a reminder, this conference is being recorded. A transcript will follow within 24 hours of this conference call. At this time, it is my pleasure to introduce Mr.